EcoDrugPlus

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSLCAG00010003604
Gene Symbol: CSF1RA
3 Cross references
63 Possible Orthologues:

Complement C1r Subcomponent

Ensembl ID : ENSLCAG00010007697
Gene Symbol: LOC108880662
2 Cross references
186 Possible Orthologues:

Complement Component 5

Ensembl ID : ENSLCAG00010024304
Gene Symbol: LOC108894954
3 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSLCAG00010015523
Gene Symbol: CRHR1
4 Cross references
207 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSLCAG00010025075
Gene Symbol: CCND1
4 Cross references
205 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSLCAG00010023129
Gene Symbol: CCND1
4 Cross references
205 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSLCAG00010000249
Gene Symbol: LOC108877824
4 Cross references
231 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSLCAG00010024783
Gene Symbol: CDK1
1 Cross references
246 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSLCAG00010013233
Gene Symbol: LOC108895329
3 Cross references
246 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSLCAG00010025960
Gene Symbol: CDK2
1 Cross references
199 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSLCAG00010026017
Gene Symbol: CDK2
1 Cross references
199 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSLCAG00010020639
Gene Symbol: CDK2
2 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).